Mass Torts | Dangerous Drugs

Pharmaceutical Law Attorneys at Simon Law Firm, P.C.Mass Torts | Dangerous Drug Litigation results from the US Food and Drug Administration (FDA) approving a drug to be “safe.” When a drug is “safe,” it means that the benefits of the drug outweigh the risks for the population the drug is intended to treat and for its intended use.

Due to the massive size of the pharmaceutical industry and the amount of capital invested in new medications, drugs are often rushed onto the marketplace without thorough and adequate testing, resulting in serious injury or death. Other times, insufficient or misleading warning labels adorn the bottles, which can cause patients to inadvertently abuse their drugs. By the time the public is made aware of these risks or the drugs are recalled, many people may already have experienced their side effects.

Types of Mass Torts | Dangerous Drug Cases:

Pharmaceutical Drug Litigation for Actos ClaimsActos® Injury Claims

Thank you for visiting our website. If you are seeking representation for an injury you may have received from taking Actos® , please take a moment and fill out our consultation form. Compensation may be available.

There is no charge or obligation for us to review your claim.

Actos® use Linked to Bladder Cancer

On June 15, 2011, the U.S. Food and Drug Administration (FDA) issued a drug safety communication warning patients and health professionals that use of pioglitazone (Actos—Takeda) for more than 1 year may be associated with an increased risk of bladder cancer. Patients who were on pioglitazone therapy for more than 12 months had a 40% increased risk of bladder cancer compared with patients who had never used the drug. The active ingredient in Actos® is also contained in other drugs, namely Actoplus Met®, Actoplus Met XR®, and Duetact®

What is Actos®?

Oral diabetes medication Actos® (generic name pioglitazone) is made by Takeda Pharmaceutical Company and co-marketed in the United States by Eli Lilly Pharmaceuticals. Actos® and related drugs are used to control type-2 diabetes in patients whose condition is not adequately controlled by diet and exercise alone.

Actos® belongs to a class of drugs called Thiazolidinedione drugs, which help to treat Type-2 diabetes by lowering blood glucose levels and increasing the body’s sensitivity to insulin. This drug may be prescribed alone (as Actos®) or in combination with other active ingredients such as metformin (sold as Actoplus met) or glimepiride (sold as duetact). A patient’s drug regiment may also include insulin or other medications in addition to those containing pioglitazone.

Type-2 diabetes, which affects approximately 18 to 20 million Americans, is characterized by high blood glucose levels caused by the body’s inability to properly use insulin. This disease, left untreated, can lead to blindness, kidney problems, and cardiovascular disease.

If you or a family member took Actos®, Actoplus Met®, Actoplus Met XR®, or Duetact® and you believe developed bladder cancer, call us toll free at 877-767-3108 or click the link below to begin the claim process. Consultations are free and our response to your claim is prompt.

Pharamceutical Litigation for Mirena IUD Injury ClaimsMirena® IUD Injury Claims

Thank you for visiting our website. Amy Gunn and Anne Brockland, attorneys at The Simon Law Firm, P.C., understand the serious nature of Mirena® IUD related injuries and will review your claim without charge or obligation. Compensation may be available.

The Simon Law Firm in St. Louis is investigating potential claims for women nationwide who have experienced serious and even debilitating or life-threatening side-effects after the implantation of the intrauterine contraception known as Mirena to prevent pregnancy or heavy menstrual bleeding.

Mirena Information

Mirena is a small, t-shaped plastic device that is inserted into the uterus by a healthcare provider and works as a contraceptive by releasing a low dose of levonorgestrel (a synthetic progestin hormone) directly into the uterus. Like other contraceptives, the hormone in Mirena is designed to prevent pregnancy by thinning the lining of the uterus, thereby preventing sperm from reaching and fertilizing an egg, and by thickening cervical mucus to prevent sperm from entering the uterus.

Mirena was approved by the Food and Drug Administration (FDA) in 2000 and is recommended to women who have had at least one child. The device can be left in place for up to five years. Mirena was also FDA-approved in 2009 to treat heavy menstrual bleeding in women who prefer intrauterine contraception as their method of birth control, the first time that the FDA has approved an intrauterine device for this purpose.

On January 14, 2010, The FDA sent a warning letter to Bayer regarding its live consumer-directed program involving Mirena representatives who traveled to consumers’ homes. The letter stated that the manufacturer “overstates the efficacy of Mirena, presents unsubstantiated claims, minimizes the risks of using Mirena, and includes false or misleading presentations regarding Mirena.”

Mirena Side Effects and Complications

Mirena may migrate from its original position after being inserted, perforating the uterus or embedding itself in the uterus. In both instances, a doctor must locate and surgically remove the device. Mirena may also migrate outside the uterine cavity and cause adhesions or scarring that can lead to infertility. Depending on the damage caused, affected women may require a complete hysterectomy, and more serious complications could result in death.

If you had to have an implanted Mirena IUD device surgically removed because it migrated from its original position (extra-uterine migration) and perforated the uterine lining, you may have a potential Mirena lawsuitiud.

Mirena lawsuits are currently being reviewed and evaluated by lawyers nationwide on behalf of women who may have suffered severe, potentially-irreversible injuries from the Mirena IUD. According to the claims, these complications could have been prevented if Bayer had properly researched Mirena and warned the public about the potential health risks associated with the device.

What you can do…

If you or a loved one have experienced any of these injuries while on Mirena, you may be entitled to compensation. Because certain laws place time limits on when you can bring your claim, it is important to have your claim evaluated in a timely manner at no charge to you by our Mirena litigation team.

Pharmaceutical Drug Litigation for Yasmin Injury ClaimsYaz, Yasmin, Beyaz and Ocella*

Yaz, Yasmin, Beyaz and Ocella contain a combination of the hormones ethinyl estradiol (estrogen) and drsp or drospirenone (progestin).

Although other birth control pills are combined hormonal oral contraceptives, drospirenone is unique to the Yaz family of medications. The serious health problems linked to Yaz and Yasmin side effects may be caused by drospirenone, which is closely related to the diuretic or water pill spironolactone. It causes the body to retain potassium, which can lead to hyperkalemia. This can cause an increased risk of Yasmin and Yaz heart problems and other health concerns.

Women could be at a particularly high risk of Yazmin and Yaz side effects if they already have elevated blood potassium levels or are taking other medications that increase potassium levels, such as NSAIDS (Motrin, Advil, Aleve), Heparin and ACE inhibitors (Capoten, Vasotec, Zestril).

Pharmaceutical Drug Litigation for Zocor Injury ClaimsZocor (simvastatin)*

The FDA warns that the 80 mg dose of Zocor carries an increased risk of muscle injury, particularly in the first year of use. The high dose of the medication may cause users to face a risk of myopathy or rhabdomyolysis; rare forms of muscle injury.

Zocor muscle injury side effects may hospitalize about 5 out of every 100,000 people who take the highest dose of the medication. The FDA has urged doctors not to start new patients on 80 mg Zocor and to only give the high dose to patients who have taken it for more than a year without side effects.

Rhabdomyolysis is a serious and potentially life-threatening condition, that causes muscle fibers to begin to break down, releasing a protein called myoglobin, which can damage the kidneys as they attempt to filter it out of the bloodstream.

Symptoms of rhabdomyolysis from Zocor may include:

  • Muscle Cramps
  • Tenderness
  • Stiffness
  • Pain
  • Spasms

The illness is usually reported in patients over 65 years of age or those who have renal impairment or uncontrolled hypothyroidism.

The FDA has also contraindicated Zocor, Vytorin and Simcor (two drugs that combine Zocor with other cholesterol medications) in combination with a wide variety of other drugs including Cyclosporin, Danazol, Noxafil, Gemcor and Lopid.

Pharmaceutical Litigation for Nuvaring Injury ClaimsNuvaRing

The use of NuvaRing birth control has been associated with an increased risk of blood clots, which could lead to serious and potentially fatal injuries. Blood clots, also known as thrombosis, can occur when blood cells clump together in the vein, restricting blood flow. If the blood clot forms in the deep veins of the legs, pelvis or arms, known as deep vein thrombosis, this could severely restrict blood flow to the heart, lungs or brain.

If a blood clot breaks off and travels through the blood stream, it could get lodged near the lung causing a pulmonary embolism. The pulmonary artery is the main intake valve of blood into the lungs, and if this artery is blocked, the body could suffer from a lack of oxygen.

The use of the NuvaRing has been found to potentially increase the risk of blood clots, deep vein thrombosis and pulmonary embolism, which could also lead to an ischemic stroke, heart attack or sudden death.

Pharmaceutical Drug Litigation for Prodaxa Injury ClaimsPradaxa (Dabigatran)

In the first year Pradaxa was on the market, there were more than 360 deaths attributed to internal bleeding from Pradaxa and some experts have raised questions as to whether the drug’s pre-approval clinical trials were valid. Complaints of Pradaxa problems have included hemorrhages, especially among the elderly and those with impaired kidney function. Other reports suggest that the drug has proven ineffective in some cases, leading to deep vein thrombosis and pulmonary embolism due to blood clots Pradaxa failed to treat. While all blood thinners carry a risk of bleeding problems, there has been growing alarm over Pradaxa deaths and the high number of complaints of bleeding from doctors and patients.

In December 2011, the FDA announced it was launching a safety review of Pradaxa, after only 14 months on the market. The agency will evaluate post-marketing reports of serious bleeding events. The investigation came about a month after the manufacturer announced it was investigating Pradaxa death reports.

Pharmaceutical Drug Litigation for Fosamax Injury ClaimsFosamax (Alendronate)*

Fosamax users appeared to be more than six times more likely to develop esophageal cancer than those who took other bisphosphonates for treatment or prevention of osteoporosis, like Boniva and Actonel. Researchers looked at adverse event reports submitted to the FDA and found 128 cases of bisphosphonate-associated esophageal cancer from 1995 through 2010. Of the 128 cases, 96 were linked to Fosamax users.

Pharmaceutical Drug Litigation for Zithromax Injury ClaimsZithromax (Z Pack, Z-Pak or Zmax)

A study was conducted by Vanderbilt University researchers, who found that patients taking a popular antibiotic called Zithromax were 2.5 times more likely to die of a heart-related problem than those taking amoxicillin. The results of the study suggest that doctors should prescribe other antibiotics for patients who are already known to have heart problems, especially problems that affect their heart rhythms.

Pharmaceutical Drug Litigation for Avodart Injury ClaimsAvodart (dutasteride)

Men taking Avodart to treat an enlarged prostate face an increased risk and danger of developing high-grade prostate cancer, which grows and spreads faster than the more common form of the disease. The FDA announced a labeling change after studies showed that while Avodart and other 5-ARIs reduced the overall risk of prostate cancer, they increased the risk that a user would develop a more serious type of tumor known as high-grade prostate cancer. The new information was added to the “Warning and Precautions” section of the label for all 5-ARIs sold in the U.S. Before you stop taking any current medications, make sure to talk with your physician. Did you know that nearly one-third of all adults in the U.S. take 5 or more medications every week? — Institute of Medicine Understand Pharmaceutical Law: Generic Drug Companies Please know that the Supreme Court ruled that generic drug companies cannot be sued for failing to warn consumers of their products’ side effects if they copy the exact warnings on the drugs’ brand-name equivalents. This decision affects millions of Americans, given that generics make up 75 percent of the prescription drugs dispensed in the U.S., justices said. Please know that because you ingested a generic drug, you may be ineligible for a lawsuit for injuries you have sustained.

 

Before you stop taking any current medications, make sure to talk with your physician.

Did you know that nearly one-third of all adults in the U.S. take 5 or more medications every week? — Institute of Medicine

Understand Pharmaceutical Law: Generic Drug Companies

Please know that the Supreme Court ruled that generic drug companies cannot be sued for failing to warn consumers of their products’ side effects if they copy the exact warnings on the drugs’ brand-name equivalents. This decision affects millions of Americans, given that generics make up 75 percent of the prescription drugs dispensed in the U.S., justices said. Please know that because you ingested a generic drug, you may be ineligible for a lawsuit for injuries you have sustained.

 

Mass Torts | Dangerous Drug Blogs